期刊文献+

米非司酮与甲氨蝶呤联合用药治疗异位妊娠的疗效分析 被引量:12

Clinical analysis of treatment for ectopic pregnancy by methotrexate combined with mifepristone
下载PDF
导出
摘要 目的探讨米非司酮与甲氨蝶呤联合配伍非手术医治输卵管异位妊娠的疗效。方法米非司酮与甲氨蝶呤(MTX)联合用药作为观察组(Ⅰ),单用MTX的病例为对照组(Ⅱ),以剖腹保守性手术的病例为对照组(Ⅲ)。结果米非司酮联合MTX治疗异位妊娠的疗效与Ⅱ组比较,疗效快,治愈率高。与Ⅲ组比有减轻患者身体伤痛、减少对生育能力的影响等优点。结论米非司酮联合MTX治疗异位妊娠疗效确切、方便经济、副作用小,并最大限度地确保输卵管的生理生育功能。 [Objective] To investigate the curative effect on the non- operative treatment for oviduct ectopic pregnancy by methotrexate combined with mifepristone. [Methods] All the cases with ectopic pregnancy were randomly divided into three groups: treatment group(Ⅰ)that treated by combined mifepristone and methotrexate,control group (Ⅱ) treated by methotrexate (MTX ), and the other control group(Ⅲ): the cases treated by traditional conservation surgery. [Results] The treatment of MTX combined with mifepristone on ectopic pregnancy acted faster and reached higher cure rate than that of group(Ⅱ). It exceeded that of group(Ⅲ) in relieving the body pain of cases, reducing the impact on bearing. [Conclusions] It is definite effective, convenient and economic to treat ectopic pregnancy by MTX combined with mifepristone.It associated with little side effect,which can protect the physiology of the oviduct bearing to the maximum extent.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第11期1709-1711,共3页 China Journal of Modern Medicine
关键词 米非司酮与MTX 输卵管损伤和干扰 输卵管异住妊娠 mifepristone and MTX the oviduct damaging and interfering oviduct ectopic pregnancy
  • 相关文献

参考文献9

二级参考文献32

  • 1戴馊英,陶敏芬,高晓玲.上海市异位妊娠调查报告[J].上海医学,1989,12(6):343-348. 被引量:103
  • 2刘伯宁,孙剑英,陶雯琪,蔡敏芳,杨美娟,虞容香,王芬娟,雷新莉,胡琼,谭慧珍,鞠以惠,苏丽珠,刘恒珠,蔡玉珍,杜影芬,申桂华,张义,石玉荣,许彬,刘荷珍,李明明,薛凤歧,付淑琴.米非司酮配伍米索前列醇终止早孕1774例分析[J].中国实用妇科与产科杂志,1994,10(4):231-232. 被引量:232
  • 3刘珠凤,郎景和,黄荣丽,连利娟,张德永.氨甲喋呤单次肌内注射治疗异位妊娠[J].中华妇产科杂志,1996,31(8):490-492. 被引量:381
  • 4谢培珍.持续性异位妊娠[J].实用妇产科杂志,1996,12(6):294-296. 被引量:23
  • 5王德智 罗焕 等.中国妇产科专家经验文集[M].沈阳:沈阳出版社,1998.120.
  • 6Vassilidon N, Balmer J. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidance that endometrial granulated lymphocytes are absent from the tubal implantation site.Fertil Steril, 1998,69 (4) :760.
  • 7Creinin MD, Drohn MA. Metrotrexate pharmacokinetics and effects in women receiving metrotrexate 50mg and 60mg per square meter for early abortion. Am J Obstet Gynecol,1997,177(6) :1444.
  • 8Isaacs JD, Mcgehee RP, Cowan BD. Life threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol, 1996,88 (4Pt2) :694.
  • 9Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gyncol,1997,176(3) :714.
  • 10Ben-Shlomo I, Eliyahu S, Yanai N, et al. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies. Fertil Steri], 1997,67 (4) :786.

共引文献1779

同被引文献60

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部